TrialHuman vaccines & immunotherapeutics2025

Immunogenicity and safety of a live attenuated varicella vaccine in children aged 1 to 12 years: A double-blind, randomized, parallel-controlled phase III clinical trial in China.

Shiyuan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.